Sort by
Keyphrases
HIV Patients
100%
Carotid Artery
100%
Intimal Thickening
100%
Protease Inhibitors
50%
Carotid Intima-media Thickness (cIMT)
50%
Intima-media Thickness
33%
Progression Rate
33%
HIV Infection
16%
Blood Pressure
16%
Race-ethnicity
16%
Ritonavir
16%
Menopause
16%
Homocysteine
16%
HIV-positive
16%
Low-density Lipoprotein Cholesterol (LDL-C)
16%
HIV-1 Protease
16%
Rate of Change
16%
University-based
16%
HIV-negative
16%
Between-group
16%
Continued Use
16%
Smoking Status
16%
Ultrasound Image
16%
Negative Control
16%
HIV Clinics
16%
Nadir CD4 Cell Count
16%
Protease Inhibitor Therapy
16%
Positive Groups
16%
Matched Cohort Study
16%
Carotid Intima-media Thickness Progression
16%
Predictors of Progression
16%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Carotid Artery
100%
Artery Intima
100%
Intima-Media Thickness
66%
Proteinase Inhibitor
44%
Human Immunodeficiency Virus Infection
11%
Cohort Analysis
11%
Outpatient
11%
Blood Pressure
11%
Cell Count
11%
Low Density Lipoprotein Cholesterol
11%
Homocysteine
11%
HIV-1 Protease
11%
Ritonavir
11%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Carotid Artery
100%
Artery Intima
100%
Human Immunodeficiency Virus Infection
11%
CD4 Lymphocyte Count
11%
Blood Pressure
11%
Low-Density Lipoprotein
11%
Homocysteine
11%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Proteinase Inhibitor
44%
Cohort Study
11%
Ritonavir
11%
Low Density Lipoprotein Cholesterol
11%
Human Immunodeficiency Virus Infection
11%
Homocysteine
11%
Human Immunodeficiency Virus Proteinase
11%
Biochemistry, Genetics and Molecular Biology
Human Immunodeficiency Virus
100%
Protease Inhibitor
40%
Cohort Study
10%
Blood Pressure
10%
CD4 Lymphocyte Count
10%
Ritonavir
10%
Homocysteine
10%
Low-Density Lipoprotein
10%
Neuroscience
Human Immunodeficiency Virus
100%
Proteinase
40%
CD4
10%
Ritonavir
10%
Low Density Lipoprotein Cholesterol
10%
Homocysteine
10%